CALR and neoplasm: Furthermore, surface-exposed calreticulin (CALR), which interacts with LDL receptor-related protein 1 (LRP1), serves as a de novo uptake signal and facilitates DC-mediated phagocytosis of tumor cells, hence resulting into the transfer of tumor-associated antigens into antigen-presenting cells [16–19].